Related Experiment Videos
Toe dystonia in Parkinson's disease: Impact of subthalamic nucleus deep brain stimulation
Chloe Laurencin1, Solveig Montaut2, Christophe Vial3
1Institut des Sciences Cognitives Marc Jeannerod, UMR 5229, CNRS, Bron, France; Service de Neurologie C, Centre Expert Parkinson, Hôpital Neurologique Pierre, Wertheimer, Hospices Civils de Lyon, Lyon, France.
Background:
Off state toe dystonia (TD) is a symptom frequently encountered in Parkinson's disease (PD), but little is known about its evolution after subthalamic nucleus deep brain stimulation (STN-DBS).
Objective:
To analyze the prevalence and the evolution of TD in PD patients candidate to STN-DBS.
Methods:
Individual data of consecutive 130 PD patients who underwent STN-DBS between 2010 and 2015 were collected.
Results:
Data were successfully collected in 95 patients. TD affect 45.3% of the patients in our cohort. TD was present in 32.7% of patients before surgery and was alleviated by STN-DBS in 48% of the cases. Motor improvement provided by STN-DBS, levodopa-equivalent treatment diminution after surgery, disease duration or age at the time of surgery were not predictive of TD evolution. A younger age at PD diagnosis was significantly associated with TD resolution.
Conclusion:
STN-DBS is partially efficient for TD but its evolution seems independent of significant predictive factors.